Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scendia Biologics
Orlando, Florida, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Scendia Biologics operates a state-licensed, FDA-registered tissue bank and supplies a portfolio of advanced allograft and biologic products focused on orthobiologic and soft tissue surgical specialties. The company was acquired by Sanara MedTech in July 2022, expanding Sanara’s surgical and biologics product offering and footprint across the U.S.[1][4][5]
- Therapeutic areas
- OtherRheumatology
- Modalities
- BiologicAllograft tissue product
- Industry
- Surgical Medical Devices
02
Partnerships
Sanara MedTech (joint venture and later acquirer)
Beyond the preview
Go deeper on Scendia Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Scendia Biologics.